Join
Live feed
·
PRReleasevia Quantisnow
Cidara Therapeutics Inc. logo
Merck & Company Inc. logo

Merck to Acquire Cidara Therapeutics, Inc., Diversifying Its Portfolio to Include Late-Phase Antiviral Agent

ByQuantisnow·Wall Street's wire, on your screen.
CDTX· Cidara Therapeutics Inc.MRK· Merck & Company Inc.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track CDTX (Cidara Therapeutics Inc.), MRK (Merck & Company Inc.) and more on Quantisnow.